The National Comprehensive Cancer Network revealed a cancer drug shortage in the U.S. and experts say the issue will likely get worse before improving.
CHARLOTTE, N.C. - Common cancer drugs are running short due to ongoing supply chain issues, forcing doctors to make tough decisions about treating patients., a new survey shows The National Comprehensive Cancer Network (NCCN) says 90% of cancer centers in the U.S. are affected by shortages of two main drugs. Doctors say this isn't the